Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Prostate Cancer

Free Subscription Articles published in Eur Urol Retrieve available abstracts of 388 articles: HTML format

Single Articles

July 2008
1. PELZER AE
   Re: under diagnosis and over diagnosis of prostate cancer.
   Eur Urol. 2008;54:234-5.
   PubMed     Related articles   
   
   
   
2. MOUL JW
   Re: Obesity-Related Plasma Hemodilution and PSA Concentration Among Men with Prostate Cancer.
   Eur Urol. 2008;54:232-3.
   PubMed     Related articles   
   
   
   June 2008
3. SCHRODER FH
   Reply to Tomasz Drewa's Letter to the Editor re: Fritz H. Schroder, Progress in Understanding Androgen-Independent Prostate Cancer (AIPC): A Review of Potential Endocrine-Mediated Mechanisms. Eur Urol. 2008;53:1129-37.
   Eur Urol. 2008;.
   PubMed     Related articles   
   
   
   
4. GIANNARINI G
   Editorial Comment on: Prostate Cancer Detection Rate in Patients with Repeated Extended 21-Sample Needle Biopsy.
   Eur Urol. 2008;.
   PubMed     Related articles   
   
   
   
5. LANGE PH
   Editorial Comment on: Prostate Cancer Detection Rate in Patients with Repeated Extended 21-Sample Needle Biopsy.
   Eur Urol. 2008;.
   PubMed     Related articles   
   
   
   
6. CAMPOS-FERNANDES JL , Bastien L, Nicolaiew N, Robert G, et al
   Prostate Cancer Detection Rate in Patients with Repeated Extended 21-Sample Needle Biopsy.
   Eur Urol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. AHYAI SA , Eichelberg C, Isbarn H, Zacharias M, et al
   Editorial Comment on: Prostate Cancer Detection Rate in Patients with Repeated Extended 21-Sample Needle Biopsy.
   Eur Urol. 2008;.
   PubMed     Related articles   
   
   
   
8. MALAVAUD B
   Editorial Comment on: Prostate-Specific Antigen Kinetics in Clinical Decision-Making During Active Surveillance for Early Prostate Cancer-A Review.
   Eur Urol. 2008;.
   PubMed     Related articles   
   
   
   
9. LOPEZ-BELTRAN A , Montironi R
   Editorial Comment on: Platelet Microparticles: A Potential Predictive Factor of Survival in Hormone-Refractory Prostate Cancer Patients Treated with Docetaxel-Based Chemotherapy.
   Eur Urol. 2008;.
   PubMed     Related articles   
   
   
   
10. RITTMASTER R
    Editorial Comment on: Prostate-Specific Antigen Kinetics in Clinical Decision-Making During Active Surveillance for Early Prostate Cancer-A Review.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
11. VAN DEN BERGH RC , Roemeling S, Roobol MJ, Wolters T, et al
    Prostate-Specific Antigen Kinetics in Clinical Decision-Making During Active Surveillance for Early Prostate Cancer-A Review.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
12. HELLEY D , Banu E, Bouziane A, Banu A, et al
    Platelet Microparticles: A Potential Predictive Factor of Survival in Hormone-Refractory Prostate Cancer Patients Treated with Docetaxel-Based Chemotherapy.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. WINK M , Frauscher F, Cosgrove D, Chapelon JY, et al
    Contrast-Enhanced Ultrasound and Prostate Cancer; A Multicentre European Research Coordination Project.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. SINGH AK
    Editorial Comment on: Contrast-Enhanced Ultrasound and Prostate Cancer; A Multicentre European Research Coordination Project.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
15. CASCIANI E , Bertini L, Gualdi G
    Re: Alessandro Sciarra, Valeria Panebianco, Stefano Salciccia, et al. Role of Dynamic Contrast-Enhanced Magnetic Resonance (MR) Imaging and Proton MR Spectroscopic Imaging in the Detection of Local Recurrence after Radical Prostatectomy for Prostate Canc
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
16. PANEBIANCO V , Passariello R
    Reply to E. Casciani, L. Bertini and G.F. Gualdi's Letter to the Editor re: Alessandro Sciarra, Valeria Panebianco, Stefano Salciccia et al. Role of Dynamic Contrast-Enhanced Resonance (MR) Imaging and Proton MR Spectroscopic Imaging in the Detection of
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
17. SARRAMON JP
    Re: Effect of alpha1-Adrenoreceptor Antagonist Exposure on Prostate Cancer Incidence: An Observational Cohort Study.
    Eur Urol. 2008;53:1300.
    PubMed     Related articles   
    
    
    
18. KLOTZ L
    Re: cumulative association of five genetic variants with prostate cancer.
    Eur Urol. 2008;53:1298-9.
    PubMed     Related articles   
    
    
    
19. CULIG Z
    Re: Stimulation of Prostate Cancer Cellular Proliferation and Invasion by the Androgen Receptor Co-activator ARA70.
    Eur Urol. 2008;53:1298.
    PubMed     Related articles   
    
    
    
20. MONGIAT-ARTUS P
    Re: androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.
    Eur Urol. 2008;53:1297.
    PubMed     Related articles   
    
    
    May 2008
21. CRAWFORD ED , Abrahamsson PA
    PSA-based Screening for Prostate Cancer: How Does It Compare with Other Cancer Screening Tests?
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
22. YARDY GW , Bicknell DC, Wilding JL, Bartlett S, et al
    Mutations in the AXIN1 Gene in Advanced Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. SCHALKEN JA
    Editorial Comment on: Mutations in the AXIN1 Gene in Advanced Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
24. CAPITANIO U , Karakiewicz PI, Jeldres C, Briganti A, et al
    Suspected Clinical T3 Prostate Cancer Is Associated with a High Rate of Negative Extended Biopsies: Clinical Implications.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
25. BRIGANTI A , Chun FK, Karakiewicz PI, Rigatti P, et al
    Is Node-Positive Prostate Cancer Always a Systemic Disease?
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
26. CHUN FK , Karakiewicz PI, Briganti A
    Prostate Cancer Diagnosis: Importance of Individualized Risk Stratification Models over PSA Alone.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
27. VICKERS AJ
    Editorial Comment on: Impact of Surgical Volume on the Rate of Lymph Node Metastases in Patients Undergoing Radical Prostatectomy and Extended Pelvic Lymph Node Dissection for Clinically Localized Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
28. BRIGANTI A , Capitanio U, Chun FK, Gallina A, et al
    Impact of Surgical Volume on the Rate of Lymph Node Metastases in Patients Undergoing Radical Prostatectomy and Extended Pelvic Lymph Node Dissection for Clinically Localized Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
29. SHARIAT SF
    Editorial Comment on: Impact of Surgical Volume on the Rate of Lymph Node Metastases in Patients Undergoing Radical Prostatectomy and Extended Pelvic Lymph Node Dissection for Clinically Localized Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
30. SHARIAT SF , Svatek RS
    Editorial Comment on: Assessment of Pathological Prostate Cancer Characteristics in Men with Favorable Biopsy Features on Predominantly Sextant Biopsy.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
31. CHUN FK , Suardi N, Capitanio U, Jeldres C, et al
    Assessment of Pathological Prostate Cancer Characteristics in Men with Favorable Biopsy Features on Predominantly Sextant Biopsy.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
32. HEIDENREICH A
    Management of Advanced Prostate Cancer: Gonadotropin-Releasing Hormone Blockers Might Improve Prognosis.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
33. DE LA ROSETTE JJ
    Editorial Comment on: Mid-term Results Demonstrate Salvage High-Intensity Focused Ultrasound (HIFU) as an Effective and Acceptably Morbid Salvage Treatment Option for Locally Radiorecurrent Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
34. CESTARI A , Guazzoni G
    Editorial Comment on: Mid-term Results Demonstrate Salvage High-Intensity Focused Ultrasound (HIFU) as an Effective and Acceptably Morbid Salvage Treatment Option for Locally Radiorecurrent Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
35. MURAT FJ , Poissonnier L, Rabilloud M, Belot A, et al
    Mid-term Results Demonstrate Salvage High-Intensity Focused Ultrasound (HIFU) as an Effective and Acceptably Morbid Salvage Treatment Option for Locally Radiorecurrent Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
36. VAN POPPEL H , Tombal B, de la Rosette JJ, Persson BE, et al
    Degarelix: A Novel Gonadotropin-Releasing Hormone (GnRH) Receptor Blocker-Results from a 1-yr, Multicentre, Randomised, Phase 2 Dosage-Finding Study in the Treatment of Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
37. WHELAN P
    Editorial Comment on: Degarelix: A Novel Gonadotropin-Releasing Hormone (GnRH) Receptor Blocker-Results from a 1-yr, Multicentre, Randomised, Phase 2 Dose-Finding Study in the Treatment of Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
38. BASTIAN PJ
    Editorial Comment on: Degarelix: a Novel Gonadotropin-Releasing Hormone (GnRH) Receptor Blocker-Results from a 1-yr, Multicentre, Randomised, Phase 2 Dose-Finding Study in the Treatment of Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
39. STEWART GD , Habib FK
    Re: androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response.
    Eur Urol. 2008;53:1085.
    PubMed     Related articles   
    
    
    April 2008
40. BARBISAN F , Mazzucchelli R, Santinelli A, Lopez-Beltran A, et al
    Overexpression of ELAV-like Protein HuR is Associated with Increased COX-2 Expression in Atrophy, High-grade Prostatic Intraepithelial Neoplasia, and Incidental Prostate Cancer in Cystoprostatectomies.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
41. SCIARRA A , Salciccia S, Panebianco V
    Proton Spectroscopic and Dynamic Contrast-Enhanced Magnetic Resonance: A Modern Approach in Prostate Cancer Imaging.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
42. HEIDENREICH A
    Reply to Magdi Kirollos' Letter to the Editor re: Axel Heidenreich, Gunnar Aus, Michel Bolla et al. EAU Guidelines on Prostate Cancer. Eur Urol 2008;53:68-80.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
43. SCHIAVINA R , Scattoni V, Castellucci P, Picchio M, et al
    (11)C-Choline Positron Emission Tomography/Computerized Tomography for Preoperative Lymph-Node Staging in Intermediate-Risk and High-Risk Prostate Cancer: Comparison with Clinical Staging Nomograms.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
44. CHUN FK
    Editorial Comment on: (11)c-Choline-Positron Emission Tomography/Computerized Tomography for Preoperative Lymph-Node Staging in Intermediate-Risk and High-Risk Prostate Cancer: Comparison with Clinical Staging Nomograms.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
45. GONTERO P , Joniau S, Van Poppel H
    Radical Prostatectomy for PSA>/=100ng/ml Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
46. GOSSELAAR C , Roobol MJ, Roemeling S, Schroder FH, et al
    The Role of the Digital Rectal Examination in Subsequent Screening Visits in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
47. WOLTERS T , Schroder FH
    Reply from Authors re: Martha K. Terris. Editorial Comment on: Is Prostate-Specific Antigen Velocity Selective for Clinically Significant Prostate Cancer In Screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
48. YOSSEPOWITCH O
    Digital Rectal Examination Remains an Important Screening Tool for Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
49. BRAUSI M , Rizzi F, Bettuzzi S
    Chemoprevention of Human Prostate Cancer by Green Tea Catechins: Two Years Later. A Follow-up Update.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
50. CHUN FK , Briganti A
    Editorial Comment on: Preliminary Results of a Novel Method to Estimate the Probability of Prostate Cancer in Men with Elevated Serum PSA Values.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
51. SPYROPOULOS E , Dellis AE
    Preliminary Results of a Novel Method to Estimate the Probability of Prostate Cancer in Men with Elevated Serum PSA Values.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
52. CIATTO S
    Editorial Comment on: Digital Rectal Examination and the Diagnosis of Prostate Cancer-a Study Based on 8 Years and Three Screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
53. GOSSELAAR C , Roobol MJ, van den Bergh RC, Wolters T, et al
    Digital Rectal Examination and the Diagnosis of Prostate Cancer-a Study Based on 8 Years and Three Screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
54. GOMELLA LG
    Re: identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911.
    Eur Urol. 2008;53:855-6.
    PubMed     Related articles    Abstract available
    
    
    
55. KATTAN MW
    Nomograms are difficult to beat.
    Eur Urol. 2008;53:671-2.
    PubMed     Related articles   
    
    
    
56. MUNTENER M , Epstein JI, Hernandez DJ, Gonzalgo ML, et al
    Prognostic significance of Gleason score discrepancies between needle biopsy and radical prostatectomy.
    Eur Urol. 2008;53:767-75.
    PubMed     Related articles    Abstract available
    
    
    March 2008
57. ADOLFSSON J
    The Management of Category T1a-T1b (Incidental) Prostate Cancer: Can We Predict Who Needs Treatment?
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
58. PINKAWA M , Gagel B, Piroth MD, Fischedick K, et al
    Erectile Dysfunction After External Beam Radiotherapy for Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
59. BRIGANTI A
    Editorial Comment on: Erectile Dysfunction After External Beam Radiotherapy for Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
60. MEULEMAN E
    Editorial Comment on: Erectile Dysfunction After External Beam Radiotherapy for Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
61. KIROLLOS M
    Re: Axel Heidenreich, Gunnar Aus, Michel Bolla et al. EAU Guidelines on Prostate Cancer. Eur Urol 2008;53:68-80.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
62. TERRIS MK
    Editorial Comment on: Is Prostate-Specific Antigen Velocity Selective for Clinically Significant Prostate Cancer In Screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
63. WOLTERS T , Roobol MJ, Bangma CH, Schroder FH, et al
    Is Prostate-Specific Antigen Velocity Selective for Clinically Significant Prostate Cancer in Screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
64. ALCARAZ A
    Management of the Hormone Sensitivity of Prostate Cancer: Where Are We Now?
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
65. IRANI J
    Rebuttal from Authors re: Antonio Alcaraz. Management of the Hormone Sensitivity of Prostate Cancer: Where Are We Now? Eur Urol: In Press. doi:10.1016/j.eururo.2008.02.042.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
66. CAGIANNOS I
    Editorial Comment on: Evaluation of Prostate Cancer Detection with Ultrasound Real-Time Elastography: A Comparison with Step Section Pathological Analysis After Radical Prostatectomy.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
67. SALOMON G , Kollerman J, Thederan I, Chun FK, et al
    Evaluation of Prostate Cancer Detection with Ultrasound Real-Time Elastography: A Comparison with Step Section Pathological Analysis after Radical Prostatectomy.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
68. SALONIA A
    Editorial Comment on: Preoperative Serum Sex Hormone-Binding Globulin as a Predictive Marker for Extraprostatic Extension of Tumor in Patients with Clinically Localized Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
69. LEE SE , Chung JS, Han BK, Park CS, et al
    Preoperative Serum Sex Hormone-Binding Globulin as a Predictive Marker for Extraprostatic Extension of Tumor in Patients with Clinically Localized Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
70. VAN AS NJ , Norman AR, Thomas K, Khoo VS, et al
    Predicting the Probability of Deferred Radical Treatment for Localised Prostate Cancer Managed by Active Surveillance.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
71. ADOLFSSON J
    Editorial Comment on: Predicting the Probability of Deferred Radical Treatment for Localised Prostate Cancer Managed by Active Surveillance.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
72. DA POZZO LF
    Editorial Comment on: The Feasibility of Prostate Cancer Detection by Triple Spectroscopy.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
73. SALOMON G , Hess T, Erbersdobler A, Eichelberg C, et al
    The Feasibility of Prostate Cancer Detection by Triple Spectroscopy.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
74. ALBRECHT W
    Editorial Comment on: Continuous versus Six Months a Year Maximal Androgen Blockade in the Management of Prostate Cancer: A Randomised Study.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
75. IRANI J , Celhay O, Hubert J, Bladou F, et al
    Continuous versus Six Months a Year Maximal Androgen Blockade in the Management of Prostate Cancer: A Randomised Study.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
76. GRAEFEN M
    Words of wisdom. Re: Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911.
    Eur Urol. 2008;53:664-5.
    PubMed     Related articles   
    
    
    
77. DE LA TAILLE A , Jones JS, Klein EA
    Open to debate. The motion: at least 18 cores are necessary to make a prostatic biopsy useful.
    Eur Urol. 2008;53:659-62.
    PubMed     Related articles   
    
    
    February 2008
78. CAPITANIO U , Scattoni V, Freschi M, Briganti A, et al
    Radical Prostatectomy for Incidental (Stage T1a-T1b) Prostate Cancer: Analysis of Predictors for Residual Disease and Biochemical Recurrence.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
79. BOLLA M
    Clinical Stage T3 Prostate Cancer: The Added Value of Three-Dimensional Conformal/Intensity-Modulated External-Beam Radiotherapy.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
80. 
    The Motion: All Men Over the Age of 50 Should be Encouraged to Take a 5alpha-Reductase Inhibitor to Prevent Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
81. NUMAO N , Kawakami S
    Reply to Rafael Boscolo-Berto, Antonio Galfano and Massimo Iafrate's Letter to the Editor re: Noburu Numao, Satoru Kawakami, Minato Yokoyama et al. Improved Accuracy in Predicting the Presence of Gleason Pattern 4/5 Prostate Cancer by Three-Dimensional 2
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
82. BOSCOLO-BERTO R , Galfano A, Iafrate M
    Re: Noburu Numao, Satoru Kawakami, Minato Yokoyama et al. Improved Accuracy in Predicting the Presence of Gleason Pattern 4/5 Prostate Cancer by Three-Dimensional 26-Core Systematic Biopsy. Eur Urol 2007;52:1663-9.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
83. ZELEFSKY M
    Rebuttal from Authors re: Michel Bolla. Clinical Stage T3 Prostate Cancer: The Added Value of Three-Dimensional Conformal/Intensity-Modulated External-Beam Radiotherapy. Eur Urol. In Press. doi:10.1016/j.eururo.2008.02.004.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
84. WHELAN P
    Endocrine Events in Prostate Cancer: A Paradigm Shift in Our Understanding?
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
85. FRISK J , Spetz AC, Hjertberg H, Petersson B, et al
    Two Modes of Acupuncture as a Treatment for Hot Flushes in Men with Prostate Cancer-A Prospective Multicenter Study with Long-Term Follow-Up.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
86. STEPHANE O
    Editorial Comment on: Combination of Bevacizumab and Docetaxel in Docetaxel-Pretreated Hormone-Refractory Prostate Cancer: A Phase 2 Study.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
87. DI LORENZO G , Figg WD, Fossa SD, Mirone V, et al
    Combination of Bevacizumab and Docetaxel in Docetaxel-Pretreated Hormone-Refractory Prostate Cancer: A Phase 2 Study.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
88. SHAW G , Price AM, Ktori E, Bisson I, et al
    Hedgehog Signalling in Androgen Independent Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
89. CHEN M , Buttyan R
    Editorial Comment on: Hedgehog Signalling in Androgen Independent Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
90. SHARIAT SF , Karakiewicz PI
    Perspectives on Prostate Cancer Biomarkers.
    Eur Urol. 2008;.
    PubMed     Related articles   
    
    
    
91. MONTIRONI R
    Words of wisdom. Re: Radial distance of extraprostatic extension measured by ocular micrometer is an independent predictor of prostate-specific antigen recurrence. A new proposal for the substaging of pT3a prostate cancer .
    Eur Urol. 2008;53:449-50.
    PubMed     Related articles   
    
    
    
92. MONGIAT-ARTUS P
    Words of wisdom. Re: Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911 .
    Eur Urol. 2008;53:448-9.
    PubMed     Related articles   
    
    
    
93. STENZL A , Merseburger AS
    Radical prostatectomy in advanced-stage and -grade disease: cure, cytoreduction, or cosmetics?
    Eur Urol. 2008;53:234-6.
    PubMed     Related articles   
    
    
    
94. PETTUS JA , Al-Ahmadie H, Barocas DA, Koppie TM, et al
    Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy.
    Eur Urol. 2008;53:370-5.
    PubMed     Related articles    Abstract available
    
    
    
95. SCHLOMM T , Nakel E, Lubke A, Buness A, et al
    Marked gene transcript level alterations occur early during radical prostatectomy.
    Eur Urol. 2008;53:333-44.
    PubMed     Related articles    Abstract available
    
    
    
96. VAN DER POEL HG
    Editorial comment on: marked gene transcript level alterations occur early during radical prostatectomy.
    Eur Urol. 2008;53:344.
    PubMed     Related articles   
    
    
    
97. LIN DW
    Editorial comment on: marked gene transcript level alterations occur early during radical prostatectomy.
    Eur Urol. 2008;53:345-6.
    PubMed     Related articles   
    
    
    January 2008
98. SCHRODER FH
    Progress in Understanding Androgen-Independent Prostate Cancer (AIPC): A Review of Potential Endocrine-Mediated Mechanisms.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
99. STEUBER T , O'Brien MF, Lilja H
    Serum Markers for Prostate Cancer: A Rational Approach to the Literature.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
100. VAN LEENDERS GJ
     Editorial Comment on: Expression and Prognostic Relevance of Annexin A3 in Prostate Cancer.
     Eur Urol. 2008;.
     PubMed     Related articles   
     
     
     
101. HARKONEN P
     Editorial Comment on: Expression and Prognostic Relevance of Annexin A3 in Prostate Cancer.
     Eur Urol. 2008;.
     PubMed     Related articles   
     
     
     
102. KOLLERMANN J , Schlomm T, Bang H, Schwall GP, et al
     Expression and Prognostic Relevance of Annexin A3 in Prostate Cancer.
     Eur Urol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
103. KATTAN MW
     Editorial Comment on: Development, Validation, and Head-to-Head Comparison of Logistic Regression-Based Nomograms and Artificial Neural Network Models Predicting Prostate Cancer on Initial Extended Biopsy.
     Eur Urol. 2008;.
     PubMed     Related articles   
     
     
     
104. KAWAKAMI S , Numao N, Okubo Y, Koga F, et al
     Development, Validation, and Head-to-Head Comparison of Logistic Regression-Based Nomograms and Artificial Neural Network Models Predicting Prostate Cancer on Initial Extended Biopsy.
     Eur Urol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
105. WHELAN P
     Editorial Comment on: Cardiovascular Mortality and Duration of Androgen Deprivation for Locally Advanced Prostate Cancer: Analysis of RTOG 92-02.
     Eur Urol. 2008;.
     PubMed     Related articles   
     
     
     
106. EFSTATHIOU JA , Bae K, Shipley WU, Hanks GE, et al
     Cardiovascular Mortality and Duration of Androgen Deprivation for Locally Advanced Prostate Cancer: Analysis of RTOG 92-02.
     Eur Urol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
107. DOEHN C
     Immunotherapy of Prostate Cancer.
     Eur Urol. 2008;.
     PubMed     Related articles   
     
     
     
108. KIESSLING A , Fussel S, Wehner R, Bachmann M, et al
     Re: Christian Doehn. Immunotherapy for Prostate Cancer. Eur Urol 2008. In press. doi:10.1016/j.eururo.2007.12.038.
     Eur Urol. 2008;.
     PubMed     Related articles   
     
     
     
109. SCHRODER FH
     Words of wisdom. Re: duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer.
     Eur Urol. 2008;53:210-1.
     PubMed     Related articles   
     
     
     
110. KATZ MD , Kibel AS
     Words of wisdom. Re: EPCA-2: a highly specific serum marker for prostate cancer.
     Eur Urol. 2008;53:210.
     PubMed     Related articles   
     
     
     
111. KLEIN EA , Kattan M, Stephenson A, Vickers A, et al
     How many lymphadenectomies does it take to cure one patient?
     Eur Urol. 2008;53:13-5.
     PubMed     Related articles   
     
     
     
112. MATTEI A , Fuechsel FG, Bhatta Dhar N, Warncke SH, et al
     The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study.
     Eur Urol. 2008;53:118-25.
     PubMed     Related articles    Abstract available
     
     
     
113. SOLOWAY MS
     Thromboembolism prophylaxis and total prostatectomy: is pharmacologic therapy required?
     Eur Urol. 2008;53:21-3.
     PubMed     Related articles   
     
     
     December 2007
114. SCIARRA A , Panebianco V, Salciccia S, Osimani M, et al
     Role of Dynamic Contrast-Enhanced Magnetic Resonance (MR) Imaging and Proton MR Spectroscopic Imaging in the Detection of Local Recurrence after Radical Prostatectomy for Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
115. HARA N
     Editorial Comment on: Role of Dynamic Contrast-Enhanced Magnetic Resonance (MR) Imaging and Proton MR Spectroscopic Imaging in the Detection of Local Recurrence after Radical Prostatectomy for Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
116. FUTTERER JJ , Barentsz JO
     Editorial Comment on: Role of Dynamic Contrast-Enhanced Magnetic Resonance (MR) Imaging and Proton MR Spectroscopic Imaging in the Detection of Local Recurrence after Radical Prostatectomy for Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
117. ZELEFSKY MJ , Yamada Y, Kollmeier MA, Shippy AM, et al
     Long-Term Outcome Following Three-Dimensional Conformal/Intensity-Modulated External-Beam Radiotherapy for Clinical Stage T3 Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
118. STUDER UE , Collette L, Whelan P, Albrecht W, et al
     Using PSA to Guide Timing of Androgen Deprivation in Patients with T0-4 N0-2 M0 Prostate Cancer not Suitable for Local Curative Treatment (EORTC 30891).
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
119. STANGELBERGER A , Schally AV, Djavan B
     New Treatment Approaches for Prostate Cancer Based on Peptide Analogues.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
120. BAMIAS A , Dimopoulos MA
     Editorial Comment on: New treatment approaches for prostate cancer based on peptide analogues.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
121. MCLEOD DG
     Editorial Comment on: New Treatment Approaches for Prostate Cancer Based on Peptide Analogues.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
122. KARAKIEWICZ PI , Suardi N, Shariat SF
     The Search for Better Prognostic Factors for Men Treated for Localized Prostate Cancer Continues.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
123. ROSARIO DJ , Lane JA, Metcalfe C, Catto JW, et al
     Contribution of a Single Repeat PSA Test to Prostate Cancer Risk Assessment: Experience from the ProtecT Study.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
124. SHARIAT SF , Karakiewicz PI
     Screening for Prostate Cancer in 2007: The PSA Era and its Challenges are not Over.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
125. SALONIA A
     Editorial Comment on: Validation of the Contemporary Epstein Criteria for Insignificant Prostate Cancer in European Men.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
126. LOPEZ-BELTRAN A , Montironi R
     Editorial Comment on: Validation of the Contemporary Epstein Criteria for Insignificant Prostate Cancer in European Men.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
127. JELDRES C , Suardi N, Walz J, Hutterer GC, et al
     Validation of the Contemporary Epstein Criteria for Insignificant Prostate Cancer in European Men.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
128. PARKER C
     Editorial comment on: Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy.
     Eur Urol. 2007;52:1651-2.
     PubMed     Related articles   
     
     
     
129. DE REIJKE TM
     Editorial comment on: Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy.
     Eur Urol. 2007;52:1650-1.
     PubMed     Related articles   
     
     
     
130. HURWITZ M
     Editorial comment on: Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution.
     Eur Urol. 2007;52:1661-2.
     PubMed     Related articles   
     
     
     
131. ALGABA F
     Words of wisdom. Re: The relationship between the extent of surgical margin positivity and prostate-specific antigen recurrence in radical prostatectomy specimens.
     Eur Urol. 2007;52:1796.
     PubMed     Related articles   
     
     
     
132. SCHRADER M , Miller K, Schostak M
     Re: Christian Barre. Open radical retropubic prostatectomy. Eur Urol 2007;52:71-80.
     Eur Urol. 2007;52:1802-3.
     PubMed     Related articles   
     
     
     November 2007
133. COOPER C
     Editorial Comment on: ADAM9 Expression is a Significant and Independent Prognostic Marker of PSA Relapse in Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
134. VALENTINI A , Bernardini S
     Editorial Comment on: ADAM9 Expression is a Significant and Independent Prognostic Marker of PSA Relapse in Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
135. FRITZSCHE FR , Jung M, Tolle A, Wild P, et al
     ADAM9 Expression is a Significant and Independent Prognostic Marker of PSA Relapse in Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
136. KIESSLING A , Fussel S, Wehner R, Bachmann M, et al
     Advances in Specific Immunotherapy for Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
137. LITWIN MS
     Editorial Comment on: High Provider Volume is Associated with Lower Rate of Secondary Therapies after Definitive Radiotherpy for Localized Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
138. YOSSEPOWITCH O
     Prostate Cancer in Men with Serum PSA of <4ng/ml: Under-diagnosed or Over-treated?
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
139. JELDRES C , Suardi N, Saad F, Montorsi F, et al
     High Provider Volume is Associated with Lower Rate of Secondary Therapies after Definitive Radiotherapy for Localized Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
140. ROACH M 3RD
     Editorial Comment on: High Provider Volume is Associated with Lower Rate of Secondary Therapies after Definitive Radiotherapy for Localized Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
141. THOMAS LN , Douglas RC, Lazier CB, Too CK, et al
     Type 1 and Type 2 5alpha-Reductase Expression in the Development and Progression of Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
142. BLANA A , Murat FJ, Walter B, Thuroff S, et al
     First Analysis of the Long-Term Results with Transrectal HIFU in Patients with Localised Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
143. EASTHAM JA
     Editorial Comment on: First Analysis of the Long-Term Results with Transrectal HIFU in Patients with Localized Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
144. FICARRA V , Novara G
     Editorial Comment on: First Analysis of the Long-Term Results with Transrectal HIFU in Patients with Localized Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
145. SCHRODER FH , Carter HB, Wolters T, van den Bergh RC, et al
     Early Detection of Prostate Cancer in 2007 Part 1: PSA and PSA Kinetics.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
146. MAFFEZZINI M
     High-Risk Prostate Cancer is Worth Further Risk Stratification.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
147. SCIARRA A
     Re: Serum bone turnover markers (PINP and ICTP) for the early detection of bone metastases in patients with prostate cancer: a longitudinal approach.
     Eur Urol. 2007;52:1531-2.
     PubMed     Related articles   
     
     
     
148. RAGHAVAN D
     Re: Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
     Eur Urol. 2007;52:1530-1.
     PubMed     Related articles   
     
     
     
149. BOORMANS JL , Schroder FH
     Re: Prostate cancer progression and survival in BRCA2 mutation carriers.
     Eur Urol. 2007;52:1529.
     PubMed     Related articles   
     
     
     
150. KATTAN MW
     Re: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin Tables) based on cases from 2000 to 2005.
     Eur Urol. 2007;52:1528.
     PubMed     Related articles   
     
     
     
151. HAMILTON RJ , Freedland SJ
     Combining prostate cancer clinical features more accurately predicts final pathologic stage than any single variable alone.
     Eur Urol. 2007;52:1380.
     PubMed     Related articles   
     
     
     
152. SCIARRA A
     Neuroendocrine differentiation in prostate adenocarcinoma.
     Eur Urol. 2007;52:1373.
     PubMed     Related articles   
     
     
     
153. GRAEFEN M
     Is the open retropubic radical prostatectomy dead?
     Eur Urol. 2007;52:1281-3.
     PubMed     Related articles   
     
     
     
154. GUILLONNEAU B
     Ceteris paribus and nomograms in medicine.
     Eur Urol. 2007;52:1287-9.
     PubMed     Related articles   
     
     
     
155. FICARRA V , Cavalleri S
     Editorial comment on: Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial.
     Eur Urol. 2007;52:1464.
     PubMed     Related articles   
     
     
     
156. AHYAI SA , Lehrich K, Kuntz RM
     Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial.
     Eur Urol. 2007;52:1456-63.
     PubMed     Related articles    Abstract available
     
     
     
157. GIANNARINI G
     Editorial comment on: Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial.
     Eur Urol. 2007;52:1463.
     PubMed     Related articles   
     
     
     
158. SIMONATO A , Gregori A, Lissiani A, Carmignani G, et al
     Two-stage transperineal management of posterior urethral strictures or bladder neck contractures associated with urinary incontinence after prostate surgery and endoscopic treatment failures.
     Eur Urol. 2007;52:1499-504.
     PubMed     Related articles    Abstract available
     
     
     
159. GALLINA A , Jeldres C, Chun FK, Shariat SF, et al
     Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.
     Eur Urol. 2007;52:1374-80.
     PubMed     Related articles    Abstract available
     
     
     October 2007
160. BARRY MJ
     Editorial Comment on: Poor Overall Survival in Septa- and Octogenarian Patients after Radical Prostatectomy and Radiotherapy for Prostate Cancer: A Population-Based Study of 6183 Men.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
161. JELDRES C , Suardi N, Walz J, Saad F, et al
     Poor Overall Survival in Septa- and Octogenarian Patients after Radical Prostatectomy and Radiotherapy for Prostate Cancer: A Population-Based Study of 6183 Men.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
162. AHYAI SA , Graefen M, Steuber T, Haese A, et al
     Contemporary Prostate Cancer Prevalence among T1c Biopsy-Referred Men with a Prostate-Specific Antigen Level </= 4.0ng per Milliliter.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
163. YOSSEPOWITCH O , Eggener SE, Serio AM, Carver BS, et al
     Secondary Therapy, Metastatic Progression, and Cancer-Specific Mortality in Men with Clinically High-Risk Prostate Cancer Treated with Radical Prostatectomy.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
164. VAN POPPEL H , Joniau S
     An Analysis of Radical Prostatectomy in Advanced Stage and High-Grade Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
165. SCHRODER FH
     Words of wisdom. Re: Statin drugs and risk of advanced prostate cancer (PC).
     Eur Urol. 2007;52:1258-9.
     PubMed     Related articles   
     
     
     
166. EGGENER S
     Editorial comment on: Methods of calculating prostate-specific antigen velocity.
     Eur Urol. 2007;52:1050-1.
     PubMed     Related articles   
     
     
     
167. AUS G
     Editorial comment on: Additional surgical intervention after radical prostatectomy, radiation therapy, androgen-deprivation therapy, or watchful waiting.
     Eur Urol. 2007;52:1043.
     PubMed     Related articles   
     
     
     
168. SCIARRA A , Di Silverio F, Salciccia S, Autran Gomez AM, et al
     Inflammation and chronic prostatic diseases: evidence for a link?
     Eur Urol. 2007;52:964-72.
     PubMed     Related articles    Abstract available
     
     
     
169. STENMAN UH
     Editorial comment on: Prostate-specific antigen improves the ability of clinical stage and biopsy gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
     Eur Urol. 2007;52:1074-5.
     PubMed     Related articles   
     
     
     
170. CHUN FK , Briganti A, Gallina A, Hutterer GC, et al
     Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
     Eur Urol. 2007;52:1067-74.
     PubMed     Related articles    Abstract available
     
     
     
171. CONNOLLY D , Black A, Murray LJ, Napolitano G, et al
     Methods of calculating prostate-specific antigen velocity.
     Eur Urol. 2007;52:1044-50.
     PubMed     Related articles    Abstract available
     
     
     
172. TOUIJER K , Kuroiwa K, Eastham JA, Vickers A, et al
     Risk-adjusted analysis of positive surgical margins following laparoscopic and retropubic radical prostatectomy.
     Eur Urol. 2007;52:1090-6.
     PubMed     Related articles    Abstract available
     
     
     
173. BERGE V , Thompson T, Blackman D
     Additional surgical intervention after radical prostatectomy, radiation therapy, androgen-deprivation therapy, or watchful waiting.
     Eur Urol. 2007;52:1036-43.
     PubMed     Related articles    Abstract available
     
     
     September 2007
174. MATTEI A , Studer UE
     Rebuttal from Authors re: Gunter Janetschek. Radioisotope-guided Lymph Node Dissection for Prostate Cancer: Potential and Limitations. Eur Urol. In press. doi:10.1016/j.eururo.2007.09.016, and Eric A. Klein, Michael Kattan, Andrew Stephenson and Andrew V
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
175. HEIDENREICH A , Aus G, Bolla M, Joniau S, et al
     EAU Guidelines on Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
176. GLINA S
     How Much are Patients Interested in Erectile Dysfunction Treatment after Radical Prostatectomy?
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
177. JANETSCHEK G
     Radioisotope-Guided Lymph Node Dissection for Prostate Cancer: Potential and Limitations.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
178. EGAWA S
     Editorial Comment on: PSA in the New Millennium: A Powerful Predictor of Prostate Cancer Prognosis and Radical Prostatectomy Outcomes - Results from the SEARCH Database.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
179. JONES JS
     Prostate Cancer: Are We Over-Diagnosing-or Under-Thinking?
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
180. BARTOLETTI R
     Editorial Comment on: PSA in the New Millennium: A Powerful Predictor of Prostate Cancer Prognosis and Radical Prostatectomy Outcomes - Results from the SEARCH Database.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
181. SCHRODER FH
     Words of wisdom. Re: detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.
     Eur Urol. 2007;52:922.
     PubMed     Related articles   
     
     
     
182. SCHRODER FH , Roobol MJ
     Words of wisdom. Re: prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years.
     Eur Urol. 2007;52:921.
     PubMed     Related articles   
     
     
     
183. KIEMENEY LA
     Words of wisdom. Re: genome-wide association study of prostate cancer identifies a second risk locus at 8q24.
     Eur Urol. 2007;52:920-1.
     PubMed     Related articles   
     
     
     
184. ITO K
     Editorial comment: factor that influence serum prostate-specific antigen levels in terms of maintaining quality within a PSA screening system.
     Eur Urol. 2007;52:714.
     PubMed     Related articles   
     
     
     
185. DAMIANO R , Di Lorenzo G, Cantiello F, De Sio M, et al
     Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis.
     Eur Urol. 2007;52:648-57.
     PubMed     Related articles    Abstract available
     
     
     
186. STOCKLE M
     Editorial comment on: tension and energy-free robotic-assisted laparoscopic radical prostatectomy with interfascial dissection of the neurovascular bundle.
     Eur Urol. 2007;52:694-5.
     PubMed     Related articles   
     
     
     
187. MATTEI A , Naspro R, Annino F, Burke D, et al
     Tension and energy-free robotic-assisted laparoscopic radical prostatectomy with interfascial dissection of the neurovascular bundles.
     Eur Urol. 2007;52:687-94.
     PubMed     Related articles    Abstract available
     
     
     
188. PUPPO P
     Repeated negative prostate biopsies with persistently elevated or rising PSA: a modern urologic dilemma.
     Eur Urol. 2007;52:639-41.
     PubMed     Related articles   
     
     
     
189. MULHALL J
     Can penile size be preserved after radical prostatectomy?
     Eur Urol. 2007;52:626-8.
     PubMed     Related articles   
     
     
     
190. BRIGANTI A , Fabbri F, Salonia A, Gallina A, et al
     Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy.
     Eur Urol. 2007;52:702-7.
     PubMed     Related articles    Abstract available
     
     
     
191. YAMAMOTO S , Yonese J, Kawakami S, Ohkubo Y, et al
     Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy.
     Eur Urol. 2007;52:696-701.
     PubMed     Related articles    Abstract available
     
     
     
192. TRPKOV K
     Editorial comment on: systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
     Eur Urol. 2007;52:743-4.
     PubMed     Related articles   
     
     
     
193. BRIGANTI A , Chun FK, Hutterer GC, Gallina A, et al
     Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
     Eur Urol. 2007;52:733-43.
     PubMed     Related articles    Abstract available
     
     
     
194. GREENE DR
     Editorial comment on: systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
     Eur Urol. 2007;52:744-5.
     PubMed     Related articles   
     
     
     
195. MOTTRIE A , Van Migem P, De Naeyer G, Schatteman P, et al
     Robot-assisted laparoscopic radical prostatectomy: oncologic and functional results of 184 cases.
     Eur Urol. 2007;52:746-50.
     PubMed     Related articles    Abstract available
     
     
     
196. ARTIBANI W
     Editorial comment on: robot-assisted laparoscopic radical prostatectomy: oncologic and functional results of 184 cases.
     Eur Urol. 2007;52:750-1.
     PubMed     Related articles   
     
     
     
197. SALAMA G , Noirot O, Bataille V, Malavaud S, et al
     Seasonality of serum prostate-specific antigen levels: a population-based study.
     Eur Urol. 2007;52:708-14.
     PubMed     Related articles    Abstract available
     
     
     
198. HUBNER WA , Schlarp OM
     Adjustable continence therapy (ProACT): evolution of the surgical technique and comparison of the original 50 patients with the most recent 50 patients at a single centre.
     Eur Urol. 2007;52:680-6.
     PubMed     Related articles    Abstract available
     
     
     August 2007
199. FREEDLAND SJ , Hotaling JM, Fitzsimons NJ, Presti JC Jr, et al
     PSA in the New Millennium: A Powerful Predictor of Prostate Cancer Prognosis and Radical Prostatectomy Outcomes - Results from the SEARCH Database.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
200. COLLETTE L
     Prostate-Specific Antigen (PSA) as a Surrogate End Point for Survival in Prostate Cancer Clinical Trials.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
201. BRYANT RJ , Hamdy FC
     Screening for Prostate Cancer: An Update.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
202. KARAKIEWICZ PI
     Editorial Comment on: Laparoscopic Extended Pelvic Lymph Node Dissection for Prostate Cancer: Description of the Surgical Technique and Initial Results.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
203. BIANCO FJ JR
     Editorial Comment on: Laparoscopic Extended Pelvic Lymph Node Dissection for Prostate Cancer: Description of the Surgical Technique and Initial Results.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
204. RIBEIRO FR , Teixeira MR
     Reply to AnnaMaria Cianciulli, Roberta Merola and Costantino Leonardo's Letter to the Editor re: Franclim R. Ribeiro, Rui Henrique, Ana T. Martins, Carmen Jeronimo, Manuel R. Teixeira. Relative Copy Number Gain of MYC in Diagnostic Needle Biopsies is an
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
205. BJARTELL A
     PSA and Prostate Cancer Screening: The Challenge of the New Millennium.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
206. BRIGANTI A
     Role of hK2 in Predicting Clinically Insignificant Prostate Cancer.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
207. CIANCIULLI A , Merola R, Leonardo C
     Re: Franclim R. Ribeiro, Rui Henrique, Ana T. Martins, Carmen Jeronimo and Manuel R. Teixeira. Relative Copy Number Gain of MYC in Diagnostic Needle Biopsies is an Independent Prognostic Factor for Prostate Cancer Patients. Eur Urol 2007;52:116-25.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
208. SALONIA A , Gallina A, Zanni G, Briganti A, et al
     Acceptance of and Discontinuation Rate from Erectile Dysfunction Oral Treatment in Patients following Bilateral Nerve-Sparing Radical Prostatectomy.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
209. SCATTONI V , Zlotta A, Montironi R, Schulman C, et al
     Extended and Saturation Prostatic Biopsy in the Diagnosis and Characterisation of Prostate Cancer: A Critical Analysis of the Literature.
     Eur Urol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
210. MIKUZ G , Algaba F, Beltran AL, Montironi R, et al
     Prostate Carcinoma: Atrophy or Not Atrophy That is the Question.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
211. GILLING PJ
     Prostate Cancer Following BPH Treatments: What the Patient Should Know.
     Eur Urol. 2007;.
     PubMed     Related articles   
     
     
     
212. JOCHAM D
     Words of wisdom. Re: Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer.
     Eur Urol. 2007;52:609-10.
     PubMed     Related articles   
     
     
     
213. THALMANN GN
     Words of wisdom. Re: Detection of occult lymph node metastases in locally advanced node-negative prostate cancer.
     Eur Urol. 2007;52:608-9.
     PubMed     Related articles   
     
     
     
214. ANDRIOLE GL
     Words of wisdom. Re: Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.
     Eur Urol. 2007;52:608.
     PubMed     Related articles   
     
     
     
215. TANEJA SS
     Words of wisdom. Re: Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening.
     Eur Urol. 2007;52:607.
     PubMed     Related articles   
     
     
     
216. YOSSEPOWITCH O
     This paper evaluates the natural history of prostate cancer in heterogeneous cohort of men treated with HT.
     Eur Urol. 2007;52:453.
     PubMed     Related articles   
     
     
     
217. LOTAN Y
     Despite PSA screening and the control by radical prostatectomy, patients treatment fails and have a PSA recurrence.
     Eur Urol. 2007;52:453-4.
     PubMed     Related articles   
     
     
     
218. DE LA TAILLE A
     Over the past decade, prostate needle biopsies have been studied widely.
     Eur Urol. 2007;52:444-5.
     PubMed     Related articles   
     
     
     
219. OYAMA N
     Editorial comment on: Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
     Eur Urol. 2007;52:429.
     PubMed     Related articles   
     
     
     
220. SCATTONI V , Picchio M, Suardi N, Messa C, et al
     Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
     Eur Urol. 2007;52:423-9.
     PubMed     Related articles    Abstract available
     
     
     
221. SCHODER H , Bochner B
     Detection and management of isolated lymph node recurrence in patients with PSA relapse.
     Eur Urol. 2007;52:310-2.
     PubMed     Related articles   
     
     
     
222. WALDKIRCH ES , Uckert S, Langnase K, Richter K, et al
     Immunohistochemical distribution of cyclic GMP-dependent protein kinase-1 in human prostate tissue.
     Eur Urol. 2007;52:495-501.
     PubMed     Related articles    Abstract available
     
     
     
223. AZADZOI KM
     Editorial comment on: Immunohistochemical distribution of cyclic GMP-dependent protein kinase-1 in human prostate tissue.
     Eur Urol. 2007;52:501-2.
     PubMed     Related articles   
     
     
     
224. KELLER H , Lehmann J, Beier J
     Radical perineal prostatectomy and simultaneous extended pelvic lymph node dissection via the same incision.
     Eur Urol. 2007;52:384-8.
     PubMed     Related articles    Abstract available
     
     
     
225. CHUN FK , Briganti A, Graefen M, Montorsi F, et al
     Development and external validation of an extended 10-core biopsy nomogram.
     Eur Urol. 2007;52:436-44.
     PubMed     Related articles    Abstract available
     
     
     July 2007
226. VAN DER POEL HG
     Editorial Comment on: Oncological and Functional Results of Antegrade Radical Retropubic Prostatectomy for the Treatment of Clinically Localised Prostate Cancer.
     Eur Urol. 2007;.
     PubMed